Clinigen Group PLC (LON:CLIN) insider Chris Rigg sold 4,955 shares of the company’s stock in a transaction that occurred on Thursday, November 23rd. The shares were sold at an average price of GBX 1,017 ($13.38), for a total transaction of £50,392.35 ($66,279.56).

Shares of Clinigen Group PLC (LON:CLIN) opened at GBX 1,012 ($13.31) on Friday. Clinigen Group PLC has a 52 week low of GBX 700 ($9.21) and a 52 week high of GBX 1,187 ($15.61).

Clinigen Group PLC (LON:CLIN) last posted its earnings results on Thursday, September 28th. The company reported GBX 41.80 ($0.55) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of GBX 41.20 ($0.54) by GBX 0.60 ($0.01). Clinigen Group PLC had a net margin of 0.70% and a return on equity of 0.98%. The business had revenue of £302.30 million for the quarter.

The company also recently announced a dividend, which will be paid on Friday, December 1st. Shareholders of record on Thursday, November 9th will be paid a GBX 3.40 ($0.04) dividend. The ex-dividend date is Thursday, November 9th. This is a boost from Clinigen Group PLC’s previous dividend of $1.60. This represents a yield of 0.32%.

COPYRIGHT VIOLATION WARNING: This article was posted by Daily Political and is owned by of Daily Political. If you are viewing this article on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark law. The correct version of this article can be read at

CLIN has been the topic of a number of recent research reports. Peel Hunt restated an “add” rating and set a GBX 1,200 ($15.78) price target on shares of Clinigen Group PLC in a research note on Thursday, September 28th. Berenberg Bank initiated coverage on shares of Clinigen Group PLC in a research note on Wednesday, November 1st. They set a “hold” rating and a GBX 1,200 ($15.78) price target on the stock. Finally, Royal Bank Of Canada restated an “outperform” rating and set a GBX 1,360 ($17.89) price target on shares of Clinigen Group PLC in a research note on Tuesday, November 7th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of GBX 1,145.83 ($15.07).

About Clinigen Group PLC

Receive News & Ratings for Clinigen Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group PLC and related companies with's FREE daily email newsletter.